NHSA (prev. SMIA)

Explore the landscape of NHSA (prev. SMIA) in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on NHSA (prev.  SMIA) to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AstraZeneca Submits FDA NDA for Orpathys–Tagrisso Combination – Targeting MET‑Altered NSCLC After EGFR TKI Failure
CompanyDrug

AstraZeneca Submits FDA NDA for Orpathys–Tagrisso Combination – Targeting MET‑Altered NSCLC After EGFR TKI Failure

HutchMed (China) Limited (NASDAQ: HCM; HKG: 0013) announced that its partner AstraZeneca plc (NYSE: AZN) has submitted a New Drug Application (NDA) to the U.S. FDA for the combination therapy…

Ascletis Reports Positive 28‑Day Proof‑of‑Concept Results for ASC50 – Oral IL‑17A Small Molecule Delivers 48.9% Placebo‑Adjusted PASI Reduction in Mild‑to‑Moderate Plaque Psoriasis

Ascletis Reports Positive 28‑Day Proof‑of‑Concept Results for ASC50 – Oral IL‑17A Small Molecule Delivers 48.9% Placebo‑Adjusted PASI Reduction in Mild‑to‑Moderate Plaque Psoriasis

CSPC's SYS6077 Wins NMPA Clinical Trial Approval – Off‑the‑Shelf Universal mRNA Cancer Vaccine for Advanced Malignant Tumors

CSPC’s SYS6077 Wins NMPA Clinical Trial Approval – Off‑the‑Shelf Universal mRNA Cancer Vaccine for Advanced Malignant Tumors

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Policy / Regulatory

NHSA’s 2022 Report: BMI Fund Income Rises 7.6%, Outgoing Expenditure Increases 2.3%

Policy / Regulatory

NHSA Unveils Updated National Reimbursement Drug List Rules for 2023

Policy / Regulatory

NHSA Unveils 2023 Work Plan for National Reimbursement Drug List Update

Policy / Regulatory

NHSA Report Highlights ‘Flying Inspections’ Impact on Medical Insurance Fund Use in 2022

Policy / Regulatory

NHSA Launches 2023 NRDL Update Process with New Work Plan and Public Feedback Period

CompanyDeals

Eccogene Secures $25 Million in Series B Financing to Advance Metabolic Disease Therapies

DealsPolicy / Regulatory

Hainan Province and NHSA Partner to Enhance Medical Insurance Industry with Real-World Data

Policy / Regulatory

NHSA Proposes Draft to Enhance Basic Medical Insurance Payment Management for Consumables

Show More